Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Prevention of Biphasic Anaphylaxis
NCT03523221Phase 1Recruiting
- Sponsor
- Hamad Medical Corporation
- Start
- Apr 2018
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in anaphylaxis comparing Dexamethasone arm with Placebo arm (2 arms). Primary endpoint: Use of single dose of oral Dexamethasone decrease revisit to health center facility with relapse of anaphylaxis at 1 week. Started Apr 2018; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
anaphylaxis
Beyond the preview
Go deeper on NCT03523221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03523221.